Hospira, Inc.  

(Public, NYSE:HSP)   Watch this stock  
Find more results for William G. Kaufman�
88.27
May 22 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range     -
52 week 46.56 - 88.45
Open     -
Vol / Avg. 0.00/1.46M
Mkt cap 15.25B
P/E 44.59
Div/yield     -
EPS 1.98
Shares 172.78M
Beta 0.67
Inst. own 83%
Jul 28, 2015
Q2 2015 Hospira Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
May 6, 2015
Hospira Inc Annual Shareholders Meeting
Apr 28, 2015
Q1 2015 Hospira Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin 6.30% 7.09%
Operating margin 11.35% 10.45%
EBITD margin - 18.27%
Return on average assets 4.50% 4.93%
Return on average equity 8.95% 10.58%
Employees 19,000 -
CDP Score - 58 E

Address

275 N Field Dr
LAKE FOREST, IL 60045-2579
United States - Map
+1-847-9376472 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Hospira, Inc., provides injectable pharmaceutical drugs and infusion technologies that it develops, manufactures, distributes, and markets worldwide. The Company’s portfolio includes generic acute-care and oncology injectables, biosimilars, and integrated infusion therapy and medication management products. Its portfolio of products is used by hospitals and alternate site providers, such as clinics, home healthcare providers, and long-term care facilities. The Company conducts operations worldwide and is managed in three segments: the Americas (such as the United States, Canada, and Latin America); Europe, the Middle East, and Africa (EMEA); and the Asia Pacific (APAC) (such as Asia, Japan, Australia, and New Zealand).

Officers and directors

F. Michael Ball Chief Executive Officer, Director
Age: 59
Bio & Compensation  - Reuters
Thomas E. Werner Senior Vice President - Finance, Chief Financial Officer
Age: 57
Bio & Compensation  - Reuters
David J. Endicott President of Hospira Medical Devices
Age: 50
Bio & Compensation  - Reuters
Kenneth F. Meyers Senior Vice President, Chief Human Resource Officer
Age: 53
Bio & Compensation  - Reuters
Mary A. Gendron Senior Vice President, Chief Information Officer
Age: 49
Bio & Compensation  - Reuters
Sumant Ramachandra M.D., Ph.D. Senior Vice President, Chief Scientific Officer
Age: 46
Bio & Compensation  - Reuters
Royce R. Bedward Senior Vice President, General Counsel, Secretary
Age: 49
Bio & Compensation  - Reuters
Brian J. Smith Senior Vice President, Special Counsel
Age: 63
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Richard John Davies Senior Vice President, Chief Commercial Officer
Age: 53
Bio & Compensation  - Reuters
Zena G. Kaufman Senior Vice President - Quality
Age: 58
Bio & Compensation  - Reuters